ES2010445A6 - Emulsion perfluoroquimica estable y metodo para su produccion. - Google Patents

Emulsion perfluoroquimica estable y metodo para su produccion.

Info

Publication number
ES2010445A6
ES2010445A6 ES8900889A ES8900889A ES2010445A6 ES 2010445 A6 ES2010445 A6 ES 2010445A6 ES 8900889 A ES8900889 A ES 8900889A ES 8900889 A ES8900889 A ES 8900889A ES 2010445 A6 ES2010445 A6 ES 2010445A6
Authority
ES
Spain
Prior art keywords
perfluorochemical
stabilized vesicles
vesicles
perfluorochemical emulsion
emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8900889A
Other languages
English (en)
Inventor
Charles Michael Heldebrant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alpha Therapeutic Corp
Original Assignee
Alpha Therapeutic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha Therapeutic Corp filed Critical Alpha Therapeutic Corp
Publication of ES2010445A6 publication Critical patent/ES2010445A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

SE CREA UNA EMULSION PERFLUOROQUIMICA ESTABLE EN VESICULAS ESTABILIZADAS. LAS VESICULAS COMPRENDEN UN POLIMERO BIOCOMPATIBLE FORMADO REVISTIENDO LAS PARTICULAS DE COMPUESTOS PERFLUOROQUIMICOS CON UNO O MAS FOSFOLIPIDOS MONOMEROS Y POLIMERIZANDO LOS MONOMEROS.
ES8900889A 1988-03-11 1989-03-10 Emulsion perfluoroquimica estable y metodo para su produccion. Expired ES2010445A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16669088A 1988-03-11 1988-03-11

Publications (1)

Publication Number Publication Date
ES2010445A6 true ES2010445A6 (es) 1989-11-01

Family

ID=22604316

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8900889A Expired ES2010445A6 (es) 1988-03-11 1989-03-10 Emulsion perfluoroquimica estable y metodo para su produccion.

Country Status (4)

Country Link
EP (1) EP0417104A4 (es)
JP (1) JPH02258050A (es)
ES (1) ES2010445A6 (es)
WO (1) WO1989008459A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219538A (en) * 1987-03-13 1993-06-15 Micro-Pak, Inc. Gas and oxygen carrying lipid vesicles
US5196199A (en) * 1990-12-14 1993-03-23 Fuisz Technologies Ltd. Hydrophilic form of perfluoro compounds and method of manufacture
DE4221269C1 (de) * 1992-06-26 1993-12-09 Lancaster Group Ag Zubereitung zur topischen Anwendung
DE4221268C2 (de) * 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
DE4221256C2 (de) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
DE4221255C2 (de) * 1992-06-26 1994-09-15 Lancaster Group Ag Phospholipide enthaltendes Kosmetikum
US5641509A (en) * 1992-06-26 1997-06-24 Lancaster Group Ag Preparation for topical use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5331209B2 (es) * 1973-10-05 1978-09-01
JPS55100312A (en) * 1979-01-25 1980-07-31 Toshiro Wada Contrast medium for blood vessel
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
US4569784A (en) * 1980-11-17 1986-02-11 Adamantech, Inc. Preparation of a gel having gas transporting capability
US4443480A (en) * 1982-04-12 1984-04-17 Children's Hospital Medical Center Artificial blood and other gas transport agents
US4497829A (en) * 1982-07-27 1985-02-05 The University Of Pennsylvania Process for preparing perfluorochemical emulsion artificial blood
US4423077A (en) * 1982-07-27 1983-12-27 The University Of Pennsylvania Perfluorochemical emulsion artificial blood
GB8407557D0 (en) * 1984-03-23 1984-05-02 Hayward J A Polymeric lipsomes
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4814446A (en) * 1985-09-17 1989-03-21 Biomed-Technology, Inc. Fluorinated triethylenediamine as an oxygen transport agent

Also Published As

Publication number Publication date
EP0417104A4 (en) 1991-10-30
JPH02258050A (ja) 1990-10-18
EP0417104A1 (en) 1991-03-20
WO1989008459A1 (en) 1989-09-21

Similar Documents

Publication Publication Date Title
OA08110A (en) Hydrophobic associative composition containing a polymer of a water-soluble monomer and an amphiphilic monomer.
AU4588489A (en) Hypocholesterolemic and antiatherosclerotic uses of bis(3,5-di-tertiary-4-hydroxyphenylthio)methane
MY102393A (en) Absorbent structures
AU6634390A (en) Crosslinked polymer electrolyte and methods of making the same
EP0251751A3 (en) Graft copolymer having dispersion stabilizing effect, a process for producing the same, and a process of emulsion polymerization using the same
MX9605678A (es) Produccion de composiciones de sustancia activa en forma de una solucion solida de la sustancia activa en una matriz de polimero, y composiciones de sustancia activa producidas por este procedimiento.
ES2150271T3 (es) Procedimiento para la preparacion de particulas de polimeros.
EP0372546A3 (en) Film-forming resin and hair dressing composition containing the same
AU4390889A (en) Chemically modified hydrophilic prepolymers and polymers
AU3496689A (en) A polymer composition comprising a hydrophilic polymer and a thermoplastic polymer
MY108860A (en) Bloodbag and method of making same
AU2307895A (en) Collagen preparation for the controlled release of active substances
EP0260941A3 (en) Anti-fungus, deodorant fiber material
AU2950889A (en) High polymer content silicone emulsions
ES2010445A6 (es) Emulsion perfluoroquimica estable y metodo para su produccion.
ES2048849T3 (es) Procedimiento para la preparacion de copolimeros de tetrafluoroetileno-etileno.
EP0365957A3 (de) Celluloseester/Polymerkombinationen, deren Herstellung und Verwendung
AU4323189A (en) Mesogens and polymers with mesogens
AU1446288A (en) Novel polymerizable vinyl monomers and vinyl resins prepared therefrom
AU5056390A (en) High surface hardness transparent resin and polymerizable monomer
AU8144687A (en) Peptides
AU631798B2 (en) New vinyl esters and their use in polymer compositions
AU4162989A (en) Reactive polyvinyl chloride and polymer products made therefrom
AU8794491A (en) An emulsion polymerised polymer
AU595503B2 (en) Polymer life enhancement in oxyanion-catalyzed polymerization

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980401